Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension

Aki Hirabayashi, Katsumasa Miyaji, Teiji Akagi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A 31-year-old woman with exertional dyspnea diagnosed as having atrial septal defect (ASD) with severe pulmonary hypertension (PH). Intravenous epoprostenol therapy was started to improve PH. Although pulmonary arterial pressure decreased, her symptoms remained in class III of WHO functional class, probably because of exacerbation of the left-to-right shunt caused by the reduction of pulmonary vascular resistance (PVR). Transcatheter atrial septal closure was therefore performed. Soon after the procedure, additional reduction in pulmonary arterial pressure was achieved. Her symptoms improved and oxygen inhalation was discontinued. One year after the procedure, although intravenous epoprostenol was still required, her symptoms had improved to class I of WHO functional class without exacerbation of PH. Transcatheter atrial septal closure after lowering PVR by intravenous epoprostenol would be a novel therapy for patients with ASD accompanied by PH.

Original languageEnglish
Pages (from-to)688-691
Number of pages4
JournalCatheterization and Cardiovascular Interventions
Volume73
Issue number5
DOIs
Publication statusPublished - Apr 1 2009

Fingerprint

Epoprostenol
Pulmonary Hypertension
Atrial Heart Septal Defects
Vascular Resistance
Arterial Pressure
Lung
Therapeutics
Dyspnea
Inhalation
Oxygen

Keywords

  • Heart catheterization
  • Therapeutics
  • Vascular resistance
  • Vasodilation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension. / Hirabayashi, Aki; Miyaji, Katsumasa; Akagi, Teiji.

In: Catheterization and Cardiovascular Interventions, Vol. 73, No. 5, 01.04.2009, p. 688-691.

Research output: Contribution to journalArticle

@article{89d40bdc28ca4145aeaf3180e556e440,
title = "Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension",
abstract = "A 31-year-old woman with exertional dyspnea diagnosed as having atrial septal defect (ASD) with severe pulmonary hypertension (PH). Intravenous epoprostenol therapy was started to improve PH. Although pulmonary arterial pressure decreased, her symptoms remained in class III of WHO functional class, probably because of exacerbation of the left-to-right shunt caused by the reduction of pulmonary vascular resistance (PVR). Transcatheter atrial septal closure was therefore performed. Soon after the procedure, additional reduction in pulmonary arterial pressure was achieved. Her symptoms improved and oxygen inhalation was discontinued. One year after the procedure, although intravenous epoprostenol was still required, her symptoms had improved to class I of WHO functional class without exacerbation of PH. Transcatheter atrial septal closure after lowering PVR by intravenous epoprostenol would be a novel therapy for patients with ASD accompanied by PH.",
keywords = "Heart catheterization, Therapeutics, Vascular resistance, Vasodilation",
author = "Aki Hirabayashi and Katsumasa Miyaji and Teiji Akagi",
year = "2009",
month = "4",
day = "1",
doi = "10.1002/ccd.21877",
language = "English",
volume = "73",
pages = "688--691",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension

AU - Hirabayashi, Aki

AU - Miyaji, Katsumasa

AU - Akagi, Teiji

PY - 2009/4/1

Y1 - 2009/4/1

N2 - A 31-year-old woman with exertional dyspnea diagnosed as having atrial septal defect (ASD) with severe pulmonary hypertension (PH). Intravenous epoprostenol therapy was started to improve PH. Although pulmonary arterial pressure decreased, her symptoms remained in class III of WHO functional class, probably because of exacerbation of the left-to-right shunt caused by the reduction of pulmonary vascular resistance (PVR). Transcatheter atrial septal closure was therefore performed. Soon after the procedure, additional reduction in pulmonary arterial pressure was achieved. Her symptoms improved and oxygen inhalation was discontinued. One year after the procedure, although intravenous epoprostenol was still required, her symptoms had improved to class I of WHO functional class without exacerbation of PH. Transcatheter atrial septal closure after lowering PVR by intravenous epoprostenol would be a novel therapy for patients with ASD accompanied by PH.

AB - A 31-year-old woman with exertional dyspnea diagnosed as having atrial septal defect (ASD) with severe pulmonary hypertension (PH). Intravenous epoprostenol therapy was started to improve PH. Although pulmonary arterial pressure decreased, her symptoms remained in class III of WHO functional class, probably because of exacerbation of the left-to-right shunt caused by the reduction of pulmonary vascular resistance (PVR). Transcatheter atrial septal closure was therefore performed. Soon after the procedure, additional reduction in pulmonary arterial pressure was achieved. Her symptoms improved and oxygen inhalation was discontinued. One year after the procedure, although intravenous epoprostenol was still required, her symptoms had improved to class I of WHO functional class without exacerbation of PH. Transcatheter atrial septal closure after lowering PVR by intravenous epoprostenol would be a novel therapy for patients with ASD accompanied by PH.

KW - Heart catheterization

KW - Therapeutics

KW - Vascular resistance

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=65549157641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549157641&partnerID=8YFLogxK

U2 - 10.1002/ccd.21877

DO - 10.1002/ccd.21877

M3 - Article

C2 - 19133673

AN - SCOPUS:65549157641

VL - 73

SP - 688

EP - 691

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 5

ER -